Burzynski: The Movie” celebrates Dr. Stanislaw Burzynski, a renowned biochemist, for having unexpectedly won a markedly intriguing, and convoluted drug-approval case against the US government. The case revolved around Antineoplastons, cancer drugs that target specific genes. Burzynski discovered Antineoplastons in mid 1970s. The movie demonstrates the immense rewards associated with drug research. When Burzynski gets the Antineoplastons approved, he becomes be the first scientist to own the distribution rights, as well as a restricted patent, for life-saving drugs that shifts paradigms individually. The movie is quite convincing particularly with respect to the viability of Antineoplastons in treating various cancers. Several cancer patients in the movie opt to use Antineoplastons rather than undergoing chemotherapy, surgery, or radiotherapy. The patients are cured of cancer. The disclosure of the relevant patient’s diagnosis and recuperation records makes the movie believable.

The movie presents Antineoplastons as having an unprecedented capability of curing brainstem glioma. Brainstem glioma characteristically affects children. It is characterized as intrinsic as well as diffuse. In the movie, the journey towards getting life-saving drugs approved by the government comes off as markedly underhanded. The government comes off as unenthusiastic pertaining to increasing the choice of the medications available to patients with life-threatening and even terminal conditions. Burzynski gets the approval for Antineoplastons after a 14-year struggle. “Burzynski: The Movie” helps Americans to explore the persuasions that make their government indifferent to the plight of those suffering from diseases such as cancer. As well, it helps them to unravel the government’s motivation in unremittingly prosecuting drug researchers such as Burzynski. From the movie, it is clear that there are authoritative and dishonest forces that are keen on maintaining an obstructive status quo in the American pharmaceutical and medical industry.